| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 22 | |
| #2 | EPO (European Patent Office) | 16 | |
| #3 | China | 8 | |
| #4 | Japan | 6 | |
| #5 | WIPO (World Intellectual Property Organization) | 5 | |
| #6 | Hungary | 4 | |
| #7 | Australia | 3 | |
| #8 | Canada | 3 | |
| #9 | Hong Kong | 3 | |
| #10 | Slovenia | 3 | |
| #11 | Montenegro | 2 | |
| #12 | Serbia | 2 | |
| #13 | Georgia | 1 | |
| #14 | Ukraine | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Medical preparations |
| # | Name | Total Patents |
|---|---|---|
| #1 | Nilsson Henrik | 51 |
| #2 | Robinson Joseph R | 34 |
| #3 | Rupp Roland | 30 |
| #4 | Andersen Peder M | 23 |
| #5 | Mueller Bernd W | 21 |
| #6 | Schoenharting Florian | 21 |
| #7 | Galetzka Christin | 14 |
| #8 | Rundfeldt Chris | 14 |
| #9 | Schönharting Florian | 10 |
| #10 | Müller Bernd W | 10 |
| Publication | Filing date | Title |
|---|---|---|
| EP2692343A1 | Combination therapy for treatment of multiple sclerosis | |
| WO2010079221A1 | Pharmaceutical composition comprising one or more fumaric acid esters | |
| CN102369001A | Pharmaceutical formulation comprising one or more fumaric acid esters in an erosion matrix | |
| GEP201606543B | Pharmaceutical formulation comprising one or more fumaric acid esters in erosion matrix | |
| EP2801354A1 | Controlled release pharmaceutical compositions comprising a fumaric acid ester |